CIMplicity (Co-pay) Savings Program: Provided by UCB for treatment with CIMZIA, this Program offers eligible commercially insured patients assistance with paying the co-pay portion of a particular treatment (similar to a co-pay card).‡
Full Answer
What is the cimplicity program for Cimzia?
*The CIMplicity program is provided as a service of UCB and is intended to support the appropriate use of CIMZIA. The CIMplicity program may be amended or canceled at any time without notice. Some program and eligibility restrictions may apply. Important Safety Information you should know about CIMZIA ® (certolizumab pegol)
How do I contact cimplicity?
Call UCBCares toll free at 1-844-599-CARE (2273) for more information. The CIMplicity ® program is provided as a service of UCB, Inc., and is intended to support the appropriate use of CIMZIA. Any CIMplicity ® program may be amended or canceled at any time without notice.
How do I contact UCB cimplicity?
Call ucbCARES™ toll free at 1-844-599-CARE (2273) for more information. The CIMplicity program is provided as a service of UCB, Inc., and is intended to support the appropriate use of CIMZIA. Any CIMplicity program may be amended or canceled at any time without notice. Some program and eligibility restrictions apply.
What is the cimplicity® covered™ eligibility?
†CIMplicity® Covered™ Eligibility: Eligible patients with a valid prescription for CIMZIA can receive treatment with the CIMZIA Prefilled Syringe at no cost for up to two years or until the patient’s coverage is approved, whichever comes first.
How do I get CIMZIA for free?
(1-866-424-6942). Eligible patients with a valid prescription for CIMZIA can receive treatment with the CIMZIA Prefilled Syringe at no cost for up to two years or until the patient's coverage is approved, whichever comes first.
Does Medicare pay for CIMZIA injections?
If you have coverage through traditional Medicare Part B, after you satisfy your deductible, Medicare covers 80% of the drug cost, and you pay the remaining 20% coinsurance. Supplemental Medicare insurance plans may also cover this 20% depending on your plan.
What is CIMZIA prescribed for?
CIMZIA is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker used in adults to: Lessen the signs and symptoms of moderately to severely active Crohn's disease (CD) in adults who have not been helped enough by usual treatments. Treat moderately to severely active rheumatoid arthritis (RA)
How long does it take for CIMZIA to work?
Cimzia injection can work as fast as 1 or 2 weeks in some people for conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Its full effectiveness can range from 4 months to 1 year based on your specific medical condition.
Does Medicare Part D cover biologics?
Biologics—usually large, complex molecules produced in a living system—are some of the most expensive drugs available, and spending for biologics is growing in Medicare Part D because they treat diseases common among Medicare beneficiaries. Biologics are estimated to cost Part D upwards of $12 billion annually.
Does Medicare cover biologic infusions?
If you have an infusion, your doctor will administer the drug through a vein in your arm. Because you obtain infusions outside the home, Part B covers them. If you have a Medigap plan, it will pay the coinsurance costs.
Is cimzia a high risk medication?
Cimzia may raise your risk for blood cancers and skin cancer. In addition, children and adolescents may develop lymphoma (cancer of the lymph nodes) and other cancers while taking drugs called tumor necrosis factor (TNF) inhibitors.
Does cimzia make you gain weight?
No, Cimzia isn't known to cause weight changes. Weight loss or weight gain weren't seen in clinical studies of Cimzia. But these may be symptoms of other serious side effects of Cimzia. Weight gain due to fluid retention could be a sign of heart failure.
Does cimzia cause hair loss?
by Drugs.com Cimzia (certolizumab) may cause a rare type of hair loss known as alopecia totalis, a complete loss of hair on the scalp. The cause for the hair loss may be due to an immune-system reaction while using Cimzia.
How long do you stay on biologics?
It should also be noted that treatment courses for each biologic agent varied, from 6 to 40 weeks of treatment. The treatment duration could have impacted the time to relapse, as many biologics are known to produce a sustained or improved response with longer treatment durations (Figure 3).
What are the most common side effects of Cimzia?
Side effects of Cimzia include:stuffy nose,sinus pain,stomach pain,diarrhea,constipation,injection site reactions (pain, redness, itching, swelling, or bleeding),upper respiratory infections (flu, cold),rash, and.More items...
What happens when you stop biologics?
Stopping biologics could make your arthritis flare. A relapse not only affects your quality of life, but could also lead to more joint-damaging inflammation, Ghosh says. If your symptoms haven't improved on your biologic, or if you're having side effects, you do have other options, Haberman says.
Is Cimzia covered under Medicare Part B or D?
CIMZIA* is now covered by Medicare Administrative Contractors administering Medicare Part B to patients in all 50 United States and US Territories.
What is the difference between Cimzia and Humira?
Both medicines are approved to treat rheumatoid arthritis, Crohn's disease, plaque psoriasis, and psoriatic arthritis, but Humira also treats several other autoimmune inflammatory diseases as well. For some diseases, Humira is safe for children, while Cimzia is only indicated for adults.
What are the side effects of Cimzia?
Side effects of Cimzia include:stuffy nose,sinus pain,stomach pain,diarrhea,constipation,injection site reactions (pain, redness, itching, swelling, or bleeding),upper respiratory infections (flu, cold),rash, and.More items...
Is Cimzia a monoclonal antibody?
Certolizumab pegol (Cimzia®) is currently the only PEGylated anti-TNFα biologic approved for the treatment of rheumatoid arthritis and Crohn disease. The product, developed by UCB, is a humanized antigen-binding fragment (Fab') of a monoclonal antibody that has been conjugated to polyethylene glycol.
How to contact CIMplicity?
For support with access and reimbursement, call CIMplicity at. 1-866-4-CIMZIA (1-866-424-6942). Eligibility and restrictions. CIMplicity Savings Program. Available to individuals with commercial prescription insurance coverage for a valid prescription of an FDA-approved indication for CIMZIA.
What is CIMZIA used for?
CIMZIA is indicated for reducing signs and symptoms of Crohn's disease (CD) and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy
What are the side effects of CIMZIA?
Angioedema, anaphylaxis, dyspnea, hypotension, rash, serum sickness, and urticaria have been reported following CIMZIA administration. If a serious allergic reaction occurs, stop CIMZIA and institute appropriate therapy. The needle shield inside the removable cap of the CIMZIA prefilled syringe contains a derivative of natural rubber latex which may cause an allergic reaction in individuals sensitive to latex.
How to get a patient enrollment form for UCB?
Reach out to your UCB sales representative, or call 1-866-4-CIMZIA (1-866-424-6942), to get a Patient Enrollment Form for your patients.
Is CIMZIA a health insurance?
Program is not health insurance, nor is participation a guarantee of insurance coverage. Limitations may apply. For initial enrollment into the Program the patient must be required by his/her commercial insurer to submit a prior authorization, or insurance coverage for the CIMZIA Prefilled Syringe must be unavailable.
Is hepatosplenic T-cell lymphoma fatal?
Postmarketing cases of hepatosplenic T-cell lymphoma (HSTCL), a rare type of T-cell lymphoma, have been reported in patients treated with TNF blockers, including CIMZIA. These cases have had a very aggressive disease course and have been fatal. The majority of reported TNF blocker cases have occurred in patients with Crohn’s disease or ulcerative colitis, and the majority were in adolescent and young adult males. Almost all of these patients had received treatment with azathioprine or 6-mercaptopurine concomitantly with a TNF blocker at or prior to diagnosis. Carefully assess the risks and benefits of treating with CIMZIA in these patient types.
Is CIMZIA available for Medicare?
Available to patients with a valid prescription for CIMZIA. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program or where otherwise prohibited by law. Other restrictions apply. View full eligibility.
What is the phone number for a CIMplicity card?
If the pharmacy approved by your insurance company does not accept or is unable to process your CIMplicity Savings Card, call 1-844-277-6853.
How to activate CIMZIA card?
If you are eligible for the CIMplicity Savings Program, as soon as you receive your card, call the number on the card to activate it so you can start saving on the cost of CIMZIA treatment. When your pharmacy calls, simply give the 10-digit number on the card as method of payment. It is that simple!
Can you cancel cimplicity?
Any CIMplicity program may be amended or canceled at any time without notice. Some program and eligibility restrictions apply. Please consult your doctor if you have any questions about your condition or treatment. You are encouraged to report negative side effects of prescription drugs to the FDA.
Does CIMZIA have a copay?
You must request the CIMZIA $0 Co-Pay Program from your healthcare professional.* If you are eligible for the Program, your doctor’s office will activate your CIMplicity Savings Card (which works as a CIMZIA co-pay card) and keep the information with your patient records in their office.
What is the phone number for a CIMplicity card?
If the pharmacy approved by your insurance company does not accept or is unable to process your CIMplicity Savings Card, call 1-844-277-6853.
How to activate CIMZIA card?
If you are eligible for the CIMplicity Savings Program, as soon as you receive your card, call the number on the card to activate it so you can start saving on the cost of CIMZIA treatment. When your pharmacy calls, simply give the 10-digit number on the card as method of payment. It is that simple!
What to call if your insurance is denied for cimzia?
If the pharmacy approved by your insurance company does not accept or is unable to process your CIMplicity Savings Card, call 1-844-277-6853. If your insurance is denied or delayed for CIMZIA treatment for psoriasis, you may still be eligible for financial assistance through the CIMplicity Covered program. Ask your dermatologist how to apply.
Can you cancel cimplicity?
Any CIMplicity program may be amended or canceled at any time without notice. Some program and eligibility restrictions apply. Please consult your doctor if you have any questions about your condition or treatment. You are encouraged to report negative side effects of prescription drugs to the FDA.
Does CIMZIA have a copay?
You must request the CIMZIA $0 Co-Pay Program from your healthcare professional.* If you are eligible for the Program, your doctor’s office will activate your CIMplicity Savings Card (which works as a CIMZIA co-pay card) and keep the information with your patient records in their office.
New User?
Please reach out to your FRM; if you don't know your FRM, please Click Here and request a rep today.
Call 1-866-4CIMZIA
Please reach out to your FRM; if you don't know your FRM, please Click Here and request a rep today.
What is a cimplicity program?
The CIMplicity program is provided as a service of UCB and is intended to support the appropriate use of CIMZIA. The CIMplicity program may be amended or canceled at any time without notice. Eligibility and restrictions apply. The CIMplicity Nursing Program does not provide medical advice and does not replace the care of the healthcare provider.
What is a CIMZIA business associate agreement?
The Business Associate Agreement that enables access to CIMplicity. Contact a CIMZIA Representative for submission instructions
What is CIMZIA used for?
CIMZIA is indicated for: Reducing signs and symptoms of Crohn’s disease (CD) and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy.
What are the side effects of CIMZIA?
Angioedema, anaphylaxis, dyspnea, hypotension, rash, serum sickness, and urticaria have been reported following CIMZIA administration. If a serious allergic reaction occurs, stop CIMZIA and institute appropriate therapy. The needle shield inside the removable cap of the CIMZIA prefilled syringe contains a derivative of natural rubber latex which may cause an allergic reaction in individuals sensitive to latex.
Is Cimzia contraindicated?
CIMZIA is contraindicated in patients with a history of hypersensitivity reaction to certolizumab pegol or to any of the excipients. Reactions have included angioedema, anaphylaxis, serum sickness, and urticaria.
Can CImzia cause TB?
Serious and sometimes fatal side effects have been reported with CIMZIA, including tuberculosis (TB), bacterial sepsis, invasive fungal infections (such as histoplasmosis), and infections due to other opportunistic pathogens (such as Legionella or Listeria). Patients should be closely monitored for the signs and symptoms of infection during and after treatment with CIMZIA. Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers, of which CIMZIA is a member. CIMZIA is not indicated for use in pediatric patients.
Can you start CIMZIA during an infection?
Do not start CIMZIA during an active infection, including localized infections. Patients older than 65 years, patients with co-morbid conditions, and/or patients taking concomitant immunosuppressants may be at greater risk of infection. If an infection develops, monitor carefully and initiate appropriate therapy.
What is CIMZIA used for?
CIMZIA is indicated for: Reducing signs and symptoms of Crohn’s disease (CD) and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy.
What are the side effects of CIMZIA?
Angioedema, anaphylaxis, dyspnea, hypotension, rash, serum sickness, and urticaria have been reported following CIMZIA administration. If a serious allergic reaction occurs, stop CIMZIA and institute appropriate therapy. The needle shield inside the removable cap of the CIMZIA prefilled syringe contains a derivative of natural rubber latex which may cause an allergic reaction in individuals sensitive to latex.
What is empiric antifungal therapy?
Consider empiric anti-fungal therapy in patients at risk for invasive fungal infections who develop severe systemic illness. Bacterial, viral, and other infections due to opportunistic pathogens, including Legionella and Listeria.
Is Cimzia contraindicated?
CIMZIA is contraindicated in patients with a history of hypersensitivity reaction to certolizumab pegol or to any of the excipients. Reactions have included angioedema, anaphylaxis, serum sickness, and urticaria.
When to discontinue CIMZIA?
Discontinue CIMZIA if a patient develops a serious infection or sepsis.
Can you start CIMZIA during an infection?
Do not start CIMZIA during an active infection, including localized infections. Patients older than 65 years, patients with co-morbid conditions, and/or patients taking concomitant immunosuppressants may be at greater risk of infection. If an infection develops, monitor carefully and initiate appropriate therapy.
Is lymphoma a risk factor for CIMZIA?
population. Patients with rheumatoid arthritis, particularly those with highly active disease, are at a higher risk of lymphoma than the general population.
How to fax CIMplicity enrollment form?
CIMplicity Enrollment and Benefits Investigation Form Complete and fax to 1-866-949-2469 By fi lling out this form, your patient will be enrolled in the CIMplicity program.
What is CIMZIA used for?
CIMZIA is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker. CIMZIA is used in adult patients to: •essen the signs and symptoms of moderately to severely active Crohn’s disease (CD) in patients who L have not been helped enough by usual treatments. •reat moderately to severely active rheumatoid arthritis (RA). T •reat active psoriatic arthritis (PsA). T •reat active ankylosing spondylitis (AS) T
What are the adverse events of CIMZIA?
In controlled Crohn’s clinical trials, the most common adverse events that occurred in ≥5% of CIMZIA patients (n=620) and more frequently than with placebo (n=614) were upper respiratory infection (20% CIMZIA, 13% placebo), urinary tract infection (7% CIMZIA, 6% placebo), and arthralgia (6% CIMZIA, 4% placebo). The proportion of patients who discontinued treatment due to adverse reactions in the controlled clinical studies was 8% for CIMZIA and 7% for placebo. In controlled RA clinical trials, the most common adverse events that occurred in ≥3% of patients taking CIMZIA 200 mg every other week with concomitant methotrexate (n=640) and more frequently than with placebo with concomitant methotrexate (n=324) were upper respiratory tract infection (6% CIMZIA, 2% placebo), headache (5% CIMZIA, 4% placebo), hypertension (5% CIMZIA, 2% placebo), nasopharyngitis (5% CIMZIA, 1% placebo), back pain (4% CIMZIA, 1% placebo), pyrexia (3% CIMZIA, 2% placebo), pharyngitis (3% CIMZIA, 1% placebo), rash (3% CIMZIA, 1% placebo), acute bronchitis (3% CIMZIA, 1% placebo), fatigue (3% CIMZIA, 2% placebo). Hypertensive adverse reactions were observed more frequently in patients receiving CIMZIA than in controls. These adverse reactions occurred more frequently among patients with a baseline history of hypertension and among patients receiving concomitant corticosteroids and non-steroidal anti-inflammatory drugs. Patients receiving CIMZIA 400 mg as monotherapy every 4 weeks in RA controlled clinical trials had similar adverse reactions to those patients receiving CIMZIA 200 mg every other week. The proportion of patients who discontinued treatment due to adverse reactions in the controlled clinical studies was 5% for CIMZIA and 2.5% for placebo. The safety profile for patients with Psoriatic Arthritis (PsA) treated with CIMZIA was similar to the safety profile seen in patients with RA and previous experience with CIMZIA. The safety profile for AS patients treated with CIMZIA was similar to the safety profile seen in patients with RA.
What happens if you get a CIMZIA?
After starting CIMZIA,if you get an infection, any sign of an infection including a fever, cough, flu-like symptoms, or have open cuts or sores on your body, call your healthcare provider right away. CIMZIA can make you more likely to get infections or make any infection that you may have worse.
What is the risk of CIMZIA?
Risk of Serious Infections and Malignancy Patients treated with CIMZIA are at an increased risk for developing serious infections that may lead to hospitalization or death. Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids.
What age can you take immunosuppressants?
Patients greater than 65 years of age, patients with co-morbid conditions, and/or patients taking concomitant immunosuppressants (e.g., corticosteroids or methotrexate) may be at a greater risk of infection.
What is empiric antifungal therapy?
Empiric anti-fungal therapy should be considered in patients at risk for invasive fungal infections who develop severe systemic illness. •acterial, viral and other infections due to opportunistic pathogens, including Legionella B and Listeria.